Systematic Review | Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines. 21 Oct, 2022 | 12:47h | UTC Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines – Cochrane Library Summary: Can the medicine dexrazoxane prevent or reduce heart damage in adults and children with cancer receiving anthracyclines? – Cochrane Library